View in EDS HTML Full Text PDF Full Text

Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma.

Saved in:
Bibliographic Details
Title: Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma.
Authors: Provez, Lien1,2 (AUTHOR) lien.provez@ugent.be, Putteman, Tom3 (AUTHOR), Landfors, Mattias4 (AUTHOR), Roels, Juliette1,2,3 (AUTHOR), Reunes, Lindy1,2 (AUTHOR), T'Sas, Sara1,2,5 (AUTHOR), Van Loocke, Wouter1,2 (AUTHOR), Lintermans, Béatrice1,2 (AUTHOR), De Coninck, Stien1,2 (AUTHOR), Thenoz, Morgan1,2 (AUTHOR), Sleeckx, Wouter2,5,6 (AUTHOR), Maćkowska-Maślak, Natalia7 (AUTHOR), Taghon, Tom2,3 (AUTHOR), Mansour, Marc R.8,9 (AUTHOR), Farah, Nadine8 (AUTHOR), Norga, Koen10 (AUTHOR), Vandenberghe, Peter11 (AUTHOR), Kotecha, Rishi S.12,13,14 (AUTHOR), Goossens, Steven2,5 (AUTHOR), Degerman, Sofie4,15 (AUTHOR)
Source: Cancers. Feb2023, Vol. 15 Issue 3, p647. 19p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers15030647